Corporate ProfilescPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (IV) delivery — with the goal of transforming infused therapies, advancing patient care and reducing healthcare costs.
Stock Quote SCPH (Common Stock) $4.68 + 0.46 (0.00%)
ExchangeNASDAQ
Volume242,028
Today's Open$4.23
Previous Close$4.68
Data as of 08/15/18 4:00 p.m. ET

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Chart
Stock chart for: SCPH.O.  Currently trading at $4.68 with a 52 week high of $18.17 and a 52 week low of $4.15.
Current News

Aug 14, 2018

scPharmaceuticals Inc. Reports Second Quarter 2018 Financial Results and Provides Business Update

Request for Type A meeting was granted by the U.S. Food and Drug Administration to discuss the Complete Response Letter received in June 2018 Balance sheet remains strong with over $100 million in cash BURLINGTON, Mass., Aug. 14, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today

Read More >

Jul 24, 2018

scPharmaceuticals Announces Appointment of Two New Directors

BURLINGTON, Mass., July 24, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, announced the appointment of two directors to its Board of Directors. Minnie Baylor-Henry, formerly with Johnson & Johnson, and Mason Freeman, M.D., a venture partner at 5AM ventures, have joined the scPhar

Read More >

Jun 28, 2018

scPharmaceuticals Appoints Frederick Hudson to Board of Directors

BURLINGTON, Mass., June 28, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, announced at its 2018 Annual Meeting of Stockholders that Frederick M. Hudson was elected to the Company’s Board of Directors, replacing Abhay Gandhi, whose term on the Board ended. Mr. Hudson will act as an in

Read More >

Upcoming Events
There are currently no events scheduled.